Clinical research of preoperative intervention of liver and spleen in the primary hepatic carcinoma
Objective: To study the practical effects of liver-spleen intervention before operation on the excision rate of primary liver cancer with excessive spleen ability. Methods: There were 24 patients with primary liver cancer and received therapeutics of liver-spleen intervention before operation. Their leucocyte and haematoblast numbers before and after the intervention were observed, and the successful cases were counted. Results: The numbers of leucocyte and haematoblast in patients after the therapeutics both rose. The data of 21 cases were in the normal range. Operation exploration was successfully made in 24 cases. Liver was partly exscinded in 18 cases. Liver in combination spleen was exscinded in 15 cases. Conclusion: Therapeutics of liver-spleen intervention before operation is convenient, safe and effective. It is able to raise excision rate and worthy to be popularized in clinic.